STUB1 and leukemia: Prior chemotherapy and radiotherapy are associated with CHIP development, mainly affecting DNA repair genes (e.g., TP53), leading to therapy-related myelodysplasia or leukemia, while bone marrow transplantation-derived CHIP mutations are associated with poor prognosis and higher mortality rates [28].